MedTrace Logo

The Incretin Effect in Patients With Gestational Diabetes Mellitus

NCT01307995 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2011-03-03

No results posted yet for this study

Summary

The aim of this study is to evaluate the reduced incretin effect observed in patients with T2DM in relation to reversibility. The incretin effect will be measured by means of OGTT and iIVGTT in 12 women with GDM during pregnancy (third trimester), and again 2-3 months post partum. It is anticipated that the incretin effect in patients with GDM is reduced - like in patients with other forms of DM. The investigators estimate that approximately 90 % of the patients with GDM re-establish a NGT 2-3 months post partum. This particular group of patients provides a unique possibility for demonstrating the reversibility of the reduced incretin effect in relation to optimal glycaemic control.

Conditions

  • Gestational Diabetes

Sponsors & Collaborators

  • University of Copenhagen

    collaborator OTHER

  • Medical University of Lodz

    lead OTHER

Principal Investigators

  • Katarzyna Cypryk, MD, PhD, Asoc. Prof. · Medical University Lodz

  • Tina Vilsbøll, MD, DMSc · University of Copenhagen

  • Marcin Kosiński, MD, PhD · Medical University Lodz

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-04-30
Primary Completion
2009-12-31
Completion
2010-05-31

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01307995 on ClinicalTrials.gov